Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 85509-1076

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 85509-1076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Ondansetron 8 mg Label Text 1)

This is a package insert for Ondansetron Tablets, USP, each containing 8 mg of ondansetron hydrochloride. The usual dosage information can be found by scanning the provided QR code. It is recommended to store the tablets in a tight, light-resistant container at a temperature between 20°C to 25°C with excursions permitted to 15° to 30°C. The tablets should be protected from light. The product has an NDC number of 85509-1076-3 and comes in a pack of 30 tablets. The tablets are intended for prescription use and are manufactured by Aurobindo Pharma Limited and repackaged by PHOENIX RX LLC in Hatboro, PA, USA. The expiration date is July 10, 2026.*

FDA Label Image

Chemical Structure (Ondansetron Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.